Research Article
Relationship between HLA-DQ Gene Polymorphism and Hepatitis B Virus Infection
Table 2
Main results of the meta-analysis of the association between HLA-DQ (rs2856718 and rs7453920) polymorphism and the risk of HBV infection.
| Polymorphism | Allele model | Homozygous model | Heterozygous model | Dominant model | Recessive mode |
| rs2856718 | G versus A | GG versus AA | AG versus AA | (AG + GG) versus AA | GG versus (AG + AA) | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | |
| HBV infection versus control | | | | | | | | | | | Overall | 0.65 (0.59–0.73) | <0.001 | 0.44 (0.36–0.55) | <0.001 | 0.66 (0.62–0.72) | 0.038 | 0.58 (0.52–0.65) | 0.008 | 0.58 (0.47–0.71) | <0.001 | Asian | 0.66 (0.58–0.75) | <0.001 | 0.45 (0.35–0.58) | <0.001 | 0.70 (0.64–0.76) | 0.449 | 0.61 (0.54–0.69) | 0.016 | 0.56 (0.44–0.71) | <0.001 | Caucasian | 0.63 (0.50–0.78) | 0.0082 | 0.41 (0.24–0.70) | 0.0023 | 0.46 (0.37–0.58) | 0.704 | 0.48 (0.39–0.59) | 0.631 | 0.63 (0.38–1.06) | 0.004 | HBV infection versus NC | | | | | | | | | | | Overall | 0.75 (0.68–0.82) | <0.001 | 0.57 (0.48–0.59) | 0.001 | 0.65 (0.51–0.81) | <0.001 | 0.63 (0.52–0.76) | <0.001 | 0.74 (0.63–0.87) | <0.001 | Asian | 0.79 (0.72–0.87) | 0.002 | 0.64 (0.53–0.77) | 0.005 | 0.78 (0.69–0.90) | 0.024 | 0.73 (0.64–0.85) | 0.006 | 0.74 (0.64–0.85) | 0.045 | Caucasian | 0.64 (0.56–0.73) | 0.642 | 0.41 (0.31–0.54) | 0.671 | 0.41 (0.18–0.90) | <0.001 | 0.41 (0.26–0.65) | 0.015 | 0.72 (0.38–1.38) | <0.001 |
| rs7453920 | A versus G | AA versus GG | AG versus GG | AA + AG versus GG | AA versus AG + GG | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | | OR (95% CI) | |
| HBV infection versus control | | | | | | | | | | | Overall | 0.66 (0.52–0.84) | <0.001 | 0.50 (0.29–0.85) | <0.001 | 0.63 (0.52–0.77) | 0.001 | 0.62 (0.50–0.78) | 0.111 | 0.57 (0.35–0.92) | 0.001 | Asian | 0.57 (0.49–0.65) | 0.156 | 0.35 (0.23–0.53) | 0.617 | 0.57 (0.48–0.67) | 0.107 | 0.55 (0.46–0.64) | 0.020 | 0.40 (0.26–0.60) | 0.659 | Caucasian | 0.83 (0.58–1.19) | 0.006 | 0.88 (0.51–1.52) | 0.098 | 0.77 (0.55–1.08) | 0.074 | 0.78 (0.52–1.15) | <0.001 | 1.01 (0.68–1.51) | 0.218 | HBV infection versus NC | | | | | | | | | | | Overall | 0.61 (0.51–0.72) | <0.001 | 0.48 (0.29–0.78) | <0.001 | 0.58 (0.51–0.65) | 0.006 | 0.57 (0.50–0.66) | <0.001 | 0.54 (0.34–0.86) | <0.001 | Asian | 0.55 (0.51–0.60) | 0.570 | 0.36 (0.26–0.50) | 0.419 | 0.55 (0.50–0.60) | 0.323 | 0.53 (0.49–0.58) | 0.521 | 0.41 (0.29–0.57) | 0.401 | Caucasian | 0.80 (0.67–1.35) | <0.001 | 0.83 (0.33–2.08) | 0.002 | 0.70 (0.45–1.08) | 0.012 | 0.72 (0.42–1.24) | <0.001 | 0.96 (0.44–2.07) | 0.007 |
|
|
NC: natural clearance; : value of heterogeneity test.
|